|
|
|
Insider
Information: |
Hantson Ludwig |
Relationship: |
Director |
City: |
Deerfield |
State: |
IL |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
130,180 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$6,995,729 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
130,180 |
|
|
Total
Value |
$6,995,729 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Baxter International Inc |
BAX |
Corporate Vice President |
2015-06-01 |
109,990 |
2010-05-07 |
0 |
Premium* |
|
Baxalta Inc |
BXLT |
President and CEO, Dir... |
2016-06-03 |
0 |
2015-07-01 |
0 |
Premium* |
|
Alexion Pharmaceuticals Inc |
ALXN |
CEO, Director |
2021-07-21 |
9,098 |
2017-03-29 |
0 |
Premium* |
|
Hologic Inc |
HOLX |
Director |
2024-03-07 |
11,092 |
2018-11-21 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
57 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BXLT |
Baxalta Inc |
President and CEO |
|
2016-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
7,973 |
220,498 |
0 |
- |
|
BXLT |
Baxalta Inc |
Chairman of the Board and CEO |
|
2016-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
203,459 |
423,955 |
0 |
- |
|
BXLT |
Baxalta Inc |
Chairman of the Board and CEO |
|
2016-03-03 |
4 |
D |
$39.30 |
$238,708 |
D/D |
(6,074) |
417,881 |
0 |
- |
|
BXLT |
Baxalta Inc |
President and CEO |
|
2016-06-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(435,102) |
0 |
0 |
- |
|
BXLT |
Baxalta Inc |
President and CEO |
|
2016-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
16,356 |
435,102 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
CEO |
|
2017-03-29 |
4 |
A |
$0.00 |
$0 |
D/D |
28,725 |
57,450 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
CEO |
|
2017-06-14 |
4 |
B |
$116.72 |
$1,167,200 |
D/D |
10,000 |
38,725 |
2.81 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
CEO |
|
2018-01-02 |
4 |
S |
$121.63 |
$310,521 |
D/D |
(2,553) |
36,172 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
CEO |
|
2018-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
95,253 |
131,425 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
CEO |
|
2018-02-08 |
4 |
S |
$116.31 |
$1,540,526 |
D/D |
(13,245) |
118,180 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
CEO |
|
2018-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
35,760 |
153,940 |
0 |
- |
|
HOLX |
Hologic Inc |
Director |
|
2018-11-21 |
4 |
A |
$0.00 |
$0 |
D/D |
659 |
659 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
CEO |
|
2018-12-31 |
4 |
S |
$95.85 |
$310,937 |
D/D |
(3,244) |
150,696 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
CEO |
|
2019-02-07 |
4 |
D |
$119.57 |
$1,556,204 |
D/D |
(13,015) |
137,681 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
CEO |
|
2019-02-28 |
4 |
D |
$132.92 |
$537,396 |
D/D |
(4,043) |
133,638 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
CEO |
|
2019-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
37,198 |
170,836 |
0 |
- |
|
HOLX |
Hologic Inc |
Director |
|
2019-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,136 |
2,795 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
CEO |
|
2020-02-07 |
4 |
D |
$102.97 |
$1,315,030 |
D/D |
(12,771) |
158,065 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
CEO |
|
2020-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
44,201 |
202,266 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
CEO |
|
2020-03-02 |
4 |
D |
$90.54 |
$761,079 |
D/D |
(8,406) |
193,860 |
0 |
- |
|
HOLX |
Hologic Inc |
Director |
|
2020-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,217 |
5,012 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
CEO |
|
2020-03-30 |
4 |
D |
$85.43 |
$273,547 |
D/D |
(3,202) |
190,658 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
CEO |
|
2020-12-16 |
4 |
A |
$0.00 |
$0 |
D/D |
162,707 |
353,365 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
CEO |
|
2020-12-16 |
4 |
D |
$157.96 |
$13,520,112 |
D/D |
(85,592) |
267,773 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
CEO |
|
2021-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
83,725 |
351,498 |
0 |
- |
|
57 Records found
|
|
Page 2 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|